<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00645762</url>
  </required_header>
  <id_info>
    <org_study_id>1156-001</org_study_id>
    <nct_id>NCT00645762</nct_id>
  </id_info>
  <brief_title>Balloon REmodeling Antrostomy THErapy Study</brief_title>
  <acronym>BREATHE I</acronym>
  <official_title>Balloon REmodeling Antrostomy THErapy Study (BREATHE I)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Entellus Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Entellus Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to evaluate safety and effectiveness of a less invasive procedure to
      treat maxillary only, or maxillary and anterior ethmoid, chronic sinusitis. Additionally,
      this study will assess the feasibility of performing the procedure under local anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidences of Device-related or Procedure-related Complications</measure>
    <time_frame>Through 12 months post-procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patency of the Treated Area as Verified by CT Scan</measure>
    <time_frame>Post-treatment at 3 months</time_frame>
    <description>Post-procedure Patency was assessed using a CT scan 3 months post-procedure. The osteomeatal complex was assessed for patency by physicians.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptomatic Score Change- Sinonasal Outcome (SNOT) 20 Score Improvement</measure>
    <time_frame>Post-treatment through 12 months</time_frame>
    <description>Symptomatic change in SNOT 20 scores on a 5-point Likert scale where &quot;0&quot; = no problem to &quot;5&quot; = problem as bad as it can be were calculated. Baseline scores and 12 month post-procedure follow-up scores were calculated and compared. A score reduction of at least 0.8 (-0.8) from baseline to 12 months is considered statistically significant and clinically impactful.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Sinusitis</condition>
  <arm_group>
    <arm_group_label>Balloon Dilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Balloon dilation with FinESS device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RS-Series Rhinosinusitis Treatment System</intervention_name>
    <description>Single arm</description>
    <arm_group_label>Balloon Dilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FinESS Balloon</intervention_name>
    <arm_group_label>Balloon Dilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects age 18 or older with chronic rhinosinusitis of the maxillary or maxillary and
             anterior ethmoid sinuses

          -  A CT scan taken after maximal medical therapy (e.g., local or systemic antibiotics,
             topical steroids, etc.) must show one of the following:

               1. Narrowing of the outflow tract of the maxillary sinus ostium or infundibulum with
                  mucosal thickening of 2 mm or greater of the maxillary sinus antrum.

               2. Evidence of maxillary sinus air/liquid level.

        Exclusion Criteria:

          -  Evidence of chronic posterior ethmoid, sphenoid or frontal sinusitis

          -  Inability to understand the study or a history of non-compliance with medical advice

          -  Unwilling or unable to sign Informed Consent Form (ICF)

          -  Currently enrolled in any other pre-approval investigational study (does not apply to
             long-term post-market studies)

          -  History of any cognitive or mental health status that would interfere with study
             participation

          -  Previous sinus surgery or intervention including sinuplasty

          -  Pregnant women

          -  Severe septal deviation causing obstruction of the ostiomeatal unit

          -  History of primary ciliary dysfunction

          -  Hemophilia

          -  Currently undergoing or in the past 6 months had undergone chemotherapy for cancer or
             radiation therapy in the head or neck region

          -  History of cystic fibrosis

          -  Known Sampter's Triad (aspirin sensitivity, asthma, sinonasal polyposis)

          -  Known sinonasal tumors or obstructive lesions

          -  History of mid facial fractures or orthognathic surgery (does not include nasal
             fracture)

          -  History of insulin dependent diabetes

          -  Not able to stop anti-coagulant (e.g., warfarin) until the International Normalized
             Ratio(INR) is below 1.5

          -  Not able to stop anti-platelet (e.g., clopidogrel, aspirin, etc.) for at least 14 days
             prior to study procedure

          -  Not able to stop any non-steroidal anti-inflammatory medications and homeopathic
             medications for at least 14 days prior to the study procedure

          -  Presence of nasal polyps that may interfere with the treatment procedure

          -  Presence of features consistent with sinus fungal disease on CT or physical
             examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Stankiewicz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loyola University Medical Center, Maywood IL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Tami, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cincinnati Sinus Institute, Cincinnati OH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central California Ear, Nose and Throat Medical Group</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Cloud Ear, Nose &amp; Throat - Head and Neck Clinic</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Otolaryngology-Facial Plastic Surgery of Long Island P.C.</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charlotte Eye, Ear, Nose &amp; Throat Associates</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Ear, Nose, and Throat</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holston Medical Group</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Ear, Nose &amp; Throat Clinic</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705-1023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Sinus Center</name>
      <address>
        <city>Boerne</city>
        <state>Texas</state>
        <zip>78006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Antonio Ear, Nose, and Throat Research</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ear, Nose, Throat &amp; Plastic Surgery Associates, PS</name>
      <address>
        <city>Auburn</city>
        <state>Washington</state>
        <zip>98002</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2008</study_first_submitted>
  <study_first_submitted_qc>March 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2008</study_first_posted>
  <results_first_submitted>March 15, 2013</results_first_submitted>
  <results_first_submitted_qc>June 20, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 29, 2013</results_first_posted>
  <last_update_submitted>June 20, 2013</last_update_submitted>
  <last_update_submitted_qc>June 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic rhinosinusitis</keyword>
  <keyword>Chronic sinusitis</keyword>
  <keyword>Maxillary sinus</keyword>
  <keyword>Anterior ethmoid sinus</keyword>
  <keyword>Ethmoid infundibulum</keyword>
  <keyword>Balloon dilation</keyword>
  <keyword>Endoscopic visualization</keyword>
  <keyword>Local anesthesia</keyword>
  <keyword>Canine fossa</keyword>
  <keyword>Less invasive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrolled patients with chronic rhinosinusitis (CRS) from Ear, Nose Throat (ENT) physician practices.</recruitment_details>
      <pre_assignment_details>All patients had transantral balloon dilation of the maxillary sinus ostium and ethmoid infundibulum with the FinESS Sinus System.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>FinESS Sisnus System Balloon Dilation</title>
          <description>Transantral balloon dilation ofthe maxillary sinuses with the FinESS Sinus System.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="67"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Balloon Dilation</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="71"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.3" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidences of Device-related or Procedure-related Complications</title>
        <time_frame>Through 12 months post-procedure</time_frame>
        <population>Patients completing 12 month follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group (ALL)</title>
            <description>FinESS Balloon Dilation</description>
          </group>
        </group_list>
        <measure>
          <title>Incidences of Device-related or Procedure-related Complications</title>
          <population>Patients completing 12 month follow-up</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" spread="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patency of the Treated Area as Verified by CT Scan</title>
        <description>Post-procedure Patency was assessed using a CT scan 3 months post-procedure. The osteomeatal complex was assessed for patency by physicians.</description>
        <time_frame>Post-treatment at 3 months</time_frame>
        <population>Analysis of ostia patency done per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>FinESS Balloon Dilation</title>
          </group>
        </group_list>
        <measure>
          <title>Patency of the Treated Area as Verified by CT Scan</title>
          <description>Post-procedure Patency was assessed using a CT scan 3 months post-procedure. The osteomeatal complex was assessed for patency by physicians.</description>
          <population>Analysis of ostia patency done per protocol</population>
          <units>Ostia</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Treated Maxillary Ostia</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Symptomatic Score Change- Sinonasal Outcome (SNOT) 20 Score Improvement</title>
        <description>Symptomatic change in SNOT 20 scores on a 5-point Likert scale where &quot;0&quot; = no problem to &quot;5&quot; = problem as bad as it can be were calculated. Baseline scores and 12 month post-procedure follow-up scores were calculated and compared. A score reduction of at least 0.8 (-0.8) from baseline to 12 months is considered statistically significant and clinically impactful.</description>
        <time_frame>Post-treatment through 12 months</time_frame>
        <population>Score reduction in SNOT 20 Scale Scores. Baseline through 12 months post-procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>FinESS Balloon Arm</title>
            <description>Subjects completing 12 month post-procedure follow-up</description>
          </group>
        </group_list>
        <measure>
          <title>Symptomatic Score Change- Sinonasal Outcome (SNOT) 20 Score Improvement</title>
          <description>Symptomatic change in SNOT 20 scores on a 5-point Likert scale where &quot;0&quot; = no problem to &quot;5&quot; = problem as bad as it can be were calculated. Baseline scores and 12 month post-procedure follow-up scores were calculated and compared. A score reduction of at least 0.8 (-0.8) from baseline to 12 months is considered statistically significant and clinically impactful.</description>
          <population>Score reduction in SNOT 20 Scale Scores. Baseline through 12 months post-procedure.</population>
          <units>Scores on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 months post-procedure</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment Group (ALL)</title>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="71"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Subcutaneous emphysema of the neck and upper chest</sub_title>
                <description>Continuous positive airway pressure (CPAP) usage resumed same day as procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="71"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1.4</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="71"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Entellus Medical</name_or_title>
      <organization>Entellus Medical</organization>
      <phone>763-463-1599</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

